RRP9 and DDX21 as new biomarkers of colorectal cancer
Xiaoqian Chi,Ning Yang,Yabin Liu
DOI: https://doi.org/10.1097/md.0000000000034384
IF: 1.6
2024-02-10
Medicine
Abstract:Colorectal cancer (CRC) is one of the most common cancers in the world, with 1 million to 2 million new cases diagnosed each year. It has become the third most common cancer and the fourth leading cause of cancer-related death, with 700,000 deaths each year, second only to lung, liver, and stomach cancer. [ 1 ] Colorectal cancer is the second most common cancer in women (9.2%) and the third most common cancer in men (10%) by sex. From 1990 to 2012, the incidence of CRC increased by more than 200,000 new cases per year. Most CRC cases have been found in western countries (55%), but this trend is changing due to the rapid development in some countries in the past few years. [ 2–4 ] China has a low incidence of CRC, but its incidence has an increasing trend in many areas. The disease mostly occurs in men over middle age, especially in the age of 40 to 70 years old. The ratio of male and female is about 2:1. [ 5 ] Colorectal cancer is a common malignant tumor in the gastrointestinal tract, the early symptoms are not obvious, with the increase of the degree of cancer, the symptoms such as change of defecation habit, hematochezia, diarrhea, alternation of diarrhea and constipation, local abdominal pain, and so on. Late stage shows anemia, weight loss, and other systemic symptoms. Mutations in specific genes can lead to the onset of CRC, just like other types of cancer. These mutations can be found in oncogenes, tumor suppressor genes, and genes related to DNA repair mechanism. According to the origin of the mutation, CRC can be divided into sporadic, hereditary, and familial. [ 6–8 ] Like other malignant tumors, the cause of this disease is still unknown and can occur in any part of the colon or rectum, but rectum and sigmoid colon are the most common, and the rest are found in cecum, ascending colon, descending colon, and transverse colon in turn. Most of the cancers were adenocarcinoma, and a few were squamous cell carcinoma and mucinous carcinoma. The disease may be related to genetic factors, chromosome abnormalities, gene fusion, and other factors. Therefore, it is particularly important to study the molecular mechanism of CRC.
medicine, general & internal